Childhood Diabetes Reduction Act of 2024
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Childhood Diabetes Reduction Act of 2024 is a Senate bill introduced in the 118th Congress aimed at addressing childhood diabetes. The bill was read twice and referred to the Senate Committee on Health, Education, Labor, and Pensions on April 18, 2024. No official summary or full text is available, and the bill ultimately failed or expired without further legislative action.
This bill sought to address childhood diabetes but did not advance beyond committee referral and expired without passage.
- Introduced in the Senate during the 118th Congress as S.4195.
- Focused on health policy, specifically targeting childhood diabetes reduction.
- Referred to the Senate Committee on Health, Education, Labor, and Pensions but received no further action.
['Children at risk of or living with diabetes', 'Healthcare providers specializing in pediatric diabetes', 'Public health agencies involved in diabetes prevention and management']
['Lack of available full text limits understanding of specific provisions and implementation mechanisms.', 'No information on funding sources or enforcement mechanisms.', 'Potential challenges in oversight and measuring effectiveness due to absence of detailed bill content.']
The bill was introduced in the Senate and referred to the relevant health committee but did not progress further. It is categorized under health policy and reflects ongoing legislative interest in addressing chronic childhood diseases such as diabetes. The bill status is marked as failed or expired, indicating no enactment during the 118th Congress.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential increased awareness and legislative focus on childhood diabetes despite bill expiration.', 'Possible influence on future health legislation targeting chronic childhood conditions.', 'Limited direct impact due to failure to advance, but may inform advocacy and policy discussions.']
The absence of an official summary and full bill text restricts transparency and public understanding. This limits the ability of stakeholders to evaluate the bill's scope, funding, and enforcement provisions. The bill's failure to progress beyond committee referral further reduces opportunities for oversight and accountability.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.